133 related articles for article (PubMed ID: 26440573)
1. Abdominal aortic aneurysms and diabetes mellitus.
Pafili K; Gouni-Berthold I; Papanas N; Mikhailidis DP
J Diabetes Complications; 2015; 29(8):1330-6. PubMed ID: 26440573
[TBL] [Abstract][Full Text] [Related]
2. Diabetes mellitus as a protective factor of abdominal aortic aneurysm: Possible mechanisms.
Climent E; Benaiges D; Chillarón JJ; Flores-Le Roux JA; Pedro-Botet J
Clin Investig Arterioscler; 2018; 30(4):181-187. PubMed ID: 29580664
[TBL] [Abstract][Full Text] [Related]
3. Treatment With Small Molecule Inhibitors of Advanced Glycation End-Products Formation and Advanced Glycation End-Products-Mediated Collagen Cross-Linking Promotes Experimental Aortic Aneurysm Progression in Diabetic Mice.
Li Y; Zheng X; Guo J; Samura M; Ge Y; Zhao S; Li G; Chen X; Shoji T; Ikezoe T; Miyata M; Xu B; Dalman RL
J Am Heart Assoc; 2023 May; 12(10):e028081. PubMed ID: 37158066
[TBL] [Abstract][Full Text] [Related]
4. Advanced complicated diabetes mellitus is associated with a reduced risk of thoracic and abdominal aortic aneurysm rupture: a population-based cohort study.
Tsai CL; Lin CL; Wu YY; Shieh DC; Sung FC; Kao CH
Diabetes Metab Res Rev; 2015 Feb; 31(2):190-7. PubMed ID: 25066630
[TBL] [Abstract][Full Text] [Related]
5. Protective Role of Diabetes Mellitus on Abdominal Aortic Aneurysm Pathogenesis: Myth or Reality?
Radak D; Tanaskovic S; Katsiki N; Isenovic ER
Curr Vasc Pharmacol; 2016; 14(2):196-200. PubMed ID: 26022380
[TBL] [Abstract][Full Text] [Related]
6. Diabetes mellitus and abdominal aortic aneurysms: A review of the mechanisms underlying the negative relationship.
Dattani N; Sayers RD; Bown MJ
Diab Vasc Dis Res; 2018 Sep; 15(5):367-374. PubMed ID: 29874945
[TBL] [Abstract][Full Text] [Related]
7. Serum carboxymethyllysine concentrations are reduced in diabetic men with abdominal aortic aneurysms: Health In Men Study.
Norman PE; Davis WA; Coughlan MT; Forbes JM; Golledge J; Davis TM
J Vasc Surg; 2009 Sep; 50(3):626-31. PubMed ID: 19628355
[TBL] [Abstract][Full Text] [Related]
8. Reduced aortic wall stress in diabetes mellitus.
Astrand H; Rydén-Ahlgren A; Sundkvist G; Sandgren T; Länne T
Eur J Vasc Endovasc Surg; 2007 May; 33(5):592-8. PubMed ID: 17164093
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinases: contribution to pathogenesis, diagnosis, surveillance and treatment of abdominal aortic aneurysms.
Kadoglou NP; Liapis CD
Curr Med Res Opin; 2004 Apr; 20(4):419-32. PubMed ID: 15119978
[TBL] [Abstract][Full Text] [Related]
10. Activation of transglutaminase type 2 for aortic wall protection in a rat abdominal aortic aneurysm formation.
Munezane T; Hasegawa T; Suritala ; Tanaka A; Okada K; Okita Y
J Vasc Surg; 2010 Oct; 52(4):967-74. PubMed ID: 20615646
[TBL] [Abstract][Full Text] [Related]
11. Diabetes mellitus and aortic aneurysm rupture: a favorable association?
Theivacumar NS; Stephenson MA; Mistry H; Valenti D
Vasc Endovascular Surg; 2014 Jan; 48(1):45-50. PubMed ID: 24065625
[TBL] [Abstract][Full Text] [Related]
12. Negative association between infra-renal aortic diameter and glycaemia: the Health in Men Study.
Le MT; Jamrozik K; Davis TM; Norman PE
Eur J Vasc Endovasc Surg; 2007 May; 33(5):599-604. PubMed ID: 17307366
[TBL] [Abstract][Full Text] [Related]
13. Atherosclerotic risk factors and atherosclerotic postoperative events are associated with low inflammation in abdominal aortic aneurysms.
Hurks R; Vink A; Hoefer IE; de Vries JP; Schoneveld AH; Schermerhorn ML; den Ruijter HM; Pasterkamp G; Moll FL
Atherosclerosis; 2014 Aug; 235(2):632-41. PubMed ID: 24972144
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological treatment of abdominal aortic aneurysm.
Miyake T; Morishita R
Cardiovasc Res; 2009 Aug; 83(3):436-43. PubMed ID: 19454489
[TBL] [Abstract][Full Text] [Related]
15. Suppression of experimental abdominal aortic aneurysms in the rat by treatment with angiotensin-converting enzyme inhibitors.
Liao S; Miralles M; Kelley BJ; Curci JA; Borhani M; Thompson RW
J Vasc Surg; 2001 May; 33(5):1057-64. PubMed ID: 11331849
[TBL] [Abstract][Full Text] [Related]
16. Reduced expansion rate of abdominal aortic aneurysms in patients with diabetes may be related to aberrant monocyte-matrix interactions.
Golledge J; Karan M; Moran CS; Muller J; Clancy P; Dear AE; Norman PE
Eur Heart J; 2008 Mar; 29(5):665-72. PubMed ID: 18263873
[TBL] [Abstract][Full Text] [Related]
17. Diabetes Mellitus: Is It Protective against Aneurysm? A Narrative Review.
Patel K; Zafar MA; Ziganshin BA; Elefteriades JA
Cardiology; 2018; 141(2):107-122. PubMed ID: 30453299
[TBL] [Abstract][Full Text] [Related]
18. Diverging effects of diabetes mellitus in patients with peripheral artery disease and abdominal aortic aneurysm and the role of advanced glycation end-products: ARTERY study - protocol for a multicentre cross-sectional study.
de Vos LC; Boersema J; Hillebrands JL; Schalkwijk CG; Meerwaldt R; Breek JC; Smit AJ; Zeebregts CJ; Lefrandt JD
BMJ Open; 2017 Apr; 7(4):e012584. PubMed ID: 28400456
[TBL] [Abstract][Full Text] [Related]
19. Continuous periaortic infusion improves doxycycline efficacy in experimental aortic aneurysms.
Sho E; Chu J; Sho M; Fernandes B; Judd D; Ganesan P; Kimura H; Dalman RL
J Vasc Surg; 2004 Jun; 39(6):1312-21. PubMed ID: 15192574
[TBL] [Abstract][Full Text] [Related]
20. Role of matrix metalloproteinase inhibitors in preventing abdominal aortic aneurysm.
Aziz F; Kuivaniemi H
Ann Vasc Surg; 2007 May; 21(3):392-401. PubMed ID: 17484978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
